Parexel International Corp (PRXL)

79.53
0.06 0.08
NASDAQ : Health Care
Prev Close 79.59
Open 79.74
Day Low/High 79.45 / 79.88
52 Wk Low/High 56.00 / 76.17
Volume 524.92K
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 50.76M
Market Cap 4.04B
EPS 2.90
P/E Ratio 35.08
Div & Yield N.A. (N.A)

Latest News

Parexel Stock Rises, May Explore Sale

Parexel Stock Rises, May Explore Sale

Parexel Int'l shares were up more than 7% Monday afternoon

PAREXEL International Reports Third Quarter Fiscal Year 2017 Results

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services company, today reported financial results for the third quarter of Fiscal Year 2017, which ended on March 31, 2017.

Parexel International Announces Date Of Third Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market.

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

PAREXEL Ranked A Top CRO In CenterWatch Global Investigative Site Relationship Survey

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it was named a top contract research organization (CRO) in the CenterWatch 2017 Global...

PAREXEL Launches Patient Sensor Solution To Transform Clinical Trial Data Collection

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores,...

PAREXEL Named A FlexJobs Top 100 Company To Watch For Telecommuting And Remote Jobs In 2017

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting and Remote Jobs...

PAREXEL International Appoints Simon Harford As Senior Vice President And Chief Financial Officer

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief Financial Officer effective June 1,...

PAREXEL International To Participate At Cowen & Co. Health Care Conference And Barclays Global Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be participating at two investor conferences in March.

PAREXEL Launches ClinPhone RTSM Mobile App To Improve Supply Management And Increase Patient Safety

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone ® RTSM (randomization and trial supply management) service.

Short Interest Declines 21.7% For PRXL

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 1,064,898 share decrease in total short interest for PAREXEL International Corp. , to 3,834,977, a decrease of 21.73% since 01/13/2017.

PAREXEL International To Present At Leerink Partners Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Leerink Partners Healthcare Conference on Thursday, February 16, 2017, in New York City.

Analysts' Actions -- Cabot, International Paper, Range Resources and More

Analysts' Actions -- Cabot, International Paper, Range Resources and More

Here are Monday's top research calls, including upgrades for Cabot Oil & Gas and Range Resources, and a downgrade for International Paper.

Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More

Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More

Here are Friday's top research calls, including an upgrade for Ford and downgrades for Eaton, Altria and Ralph Lauren.

PAREXEL International Reports Second Quarter Fiscal Year 2017 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2017, which ended on December 31, 2016.

PAREXEL Announces Definitive Agreement To Acquire The Medical Affairs Company

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC...

PAREXEL's Albert Siu And Anke Nissen Accept A 2017 Training Magazine Training Top 125 Award On Behalf Of The Company. PAREXEL Ranked 38 Among The Top 125 Companies. (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been recognized among top U.

PAREXEL Expands Managed Access Programs Service Offering

PAREXEL Expands Managed Access Programs Service Offering

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an expanded Managed Access Programs service.

PAREXEL International Announces Date Of Second Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Announces Date Of Second Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter Fiscal Year 2017 on Wednesday, February 1, 2017 after the close of the stock market.

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Tuesday, January 10, 2017, in San Francisco.

PAREXEL International Announces $200 Million Accelerated Share Repurchase Program

PAREXEL International Announces $200 Million Accelerated Share Repurchase Program

PAREXEL International Corporation (Nasdaq:PRXL), a leading global biopharmaceutical services provider, announced today that the Company entered into an accelerated share repurchase agreement (ASR) with HSBC Bank USA,...

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its...

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies.